Announcements Trials

Browse Landscape

Sponsor

Conditions

Recurrence 2 Small Cell Lung Carcinoma 1 Recurrent Squamous Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pleural Effusion, Malignant 1 Ovarian Neoplasms 1 MET Positive 1 Lung Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 53 Cisplatin 52 Fluorouracil 50 Capecitabine 48 pembrolizumab 39 Leucovorin 31 Docetaxel 26 Trastuzumab 23 Paclitaxel 20 Irinotecan 20 Ramucirumab 13 Bevacizumab 12 Cetuximab 9 Radiotherapy 8 Surgical Procedures, Operative 7 S 1 (combination) 7 Nivolumab 7 Epirubicin 7 Carboplatin 6 olaparib 5 Platinum 5 Everolimus 5 Sunitinib 4 Mitomycin 4 trastuzumab deruxtecan 3 lenvatinib 3 epacadostat 3 bemarituzumab 3 apatinib 3 Saline Solution 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Stomach Neoplasms × rilotumumab × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡